Recent Strategies for Nano-based PTT Combined with Immunotherapy: from a Biomaterial Point of View

Overview

Journal Theranostics

Date 2021 Jun 23

PMID 34158866

Citations 46

Authors

Xingyue Huang

Yang Lu

Mingxue Guo

Shouying Du

Ning Han

Affiliations

Soon will be listed here.

Abstract

Cancer has been a great threat to humans for decades. Due to the limitations of monotherapy, combinational therapies such as photothermal therapy (PTT) and immunotherapy have gained increasing attention with expectation to overcome the shortfalls of each other and obtain satisfactory therapeutic outcomes. PTT can inhibit primary tumors by thermal ablation but usually fails to achieve complete eradication and cannot prevent metastasis and recurrence. Meanwhile, the efficacy of immunotherapy is usually attenuated by the weak immunogenicity of tumor and the immunosuppressive tumor microenvironment (ITM). Therefore, many recent studies have attempted to synergize PTT with immunotherapy in order to enhance the therapeutic efficacy. In this review, we aim to summarize the cutting-edge strategies in combining nano-based PTT with immunotherapy for cancer treatment. Herein, the combination strategies were mainly classified into four categories, including 1) nano-based PTT combined with antigens to induce host immune responses; 2) nano-based PTT in combination with immune adjuvants acting as vaccines; 3) nano-based PTT synergized with immune checkpoint blockade or other regulators to relieve the ITM; 4) nano-based PTT combined with CAR-T therapy or cytokine therapy for tumor treatment. The characteristics of various photothermal agents and nanoplatforms as well as the immunological mechanisms for the synergism were also introduced in detail. Finally, we discussed the existing challenges and future prospects in combined PTT and immunotherapy.

Citing Articles

Mitochondria-targeted photothermal-chemodynamic therapy enhances checkpoint blockade immunotherapy on colon cancer.

Zheng B, Wang H, Zhai S, Li J, Lu K Mater Today Bio. 2025; 31:101542.

PMID: 40018055 PMC: 11867542. DOI: 10.1016/j.mtbio.2025.101542.

Exploring the application of metal-based photothermal agents in photothermal therapy combined with immune checkpoint therapy.

Xie B, Xiao Z, Ling J, Peng Y, Chen T Front Pharmacol. 2025; 16:1553158.

PMID: 40017598 PMC: 11865196. DOI: 10.3389/fphar.2025.1553158.

Targeted intra-tumoral hyperthermia using uniquely biocompatible gold nanorods induces strong immunogenic cell death in two immunogenically 'cold' tumor models.

Kennedy B, Noftall E, Dean C, Roth A, Clark K, Rowles D Front Immunol. 2025; 15:1512543.

PMID: 39872527 PMC: 11769938. DOI: 10.3389/fimmu.2024.1512543.

Nanotechnology-Based Strategies for Safe and Effective Immunotherapy.

Hong S, Park J, Oh Y, Cho H, Kim K Molecules. 2025; 29(24.

PMID: 39769944 PMC: 11676242. DOI: 10.3390/molecules29245855.

Emerging nitric oxide gas-assisted cancer photothermal treatment.

Liang S, Liu Y, Zhu H, Liao G, Zhu W, Zhang L Exploration (Beijing). 2024; 4(6):20230163.

PMID: 39713202 PMC: 11655315. DOI: 10.1002/EXP.20230163.

References

Li Y, Liu X, Pan W, Li N, Tang B . Photothermal therapy-induced immunogenic cell death based on natural melanin nanoparticles against breast cancer. Chem Commun (Camb). 2020; 56(9):1389-1392. DOI: 10.1039/c9cc08447a. View

Huang Z, Lv F, Wang J, Cao S, Liu Z, Liu Y . RGD-modified PEGylated paclitaxel nanocrystals with enhanced stability and tumor-targeting capability. Int J Pharm. 2018; 556:217-225. DOI: 10.1016/j.ijpharm.2018.12.023. View

An F, Yang Z, Zheng M, Mei T, Deng G, Guo P . Rationally assembled albumin/indocyanine green nanocomplex for enhanced tumor imaging to guide photothermal therapy. J Nanobiotechnology. 2020; 18(1):49. PMC: 7079369. DOI: 10.1186/s12951-020-00603-8. View

Hwang H, Shin H, Han J, Na K . Combination of photodynamic therapy (PDT) and anti-tumor immunity in cancer therapy. J Pharm Investig. 2019; 48(2):143-151. PMC: 6323106. DOI: 10.1007/s40005-017-0377-x. View

Yata T, Takahashi Y, Tan M, Nakatsuji H, Ohtsuki S, Murakami T . DNA nanotechnology-based composite-type gold nanoparticle-immunostimulatory DNA hydrogel for tumor photothermal immunotherapy. Biomaterials. 2017; 146:136-145. DOI: 10.1016/j.biomaterials.2017.09.014. View

Nam J, Son S, Ochyl L, Kuai R, Schwendeman A, Moon J . Chemo-photothermal therapy combination elicits anti-tumor immunity against advanced metastatic cancer. Nat Commun. 2018; 9(1):1074. PMC: 5852008. DOI: 10.1038/s41467-018-03473-9. View

Chen P, Pan W, Wu C, Yeh C, Korupalli C, Luo P . Modulation of tumor microenvironment using a TLR-7/8 agonist-loaded nanoparticle system that exerts low-temperature hyperthermia and immunotherapy for in situ cancer vaccination. Biomaterials. 2019; 230:119629. DOI: 10.1016/j.biomaterials.2019.119629. View

Li J, Zhang C, Gong S, Li X, Yu M, Qian C . A nanoscale photothermal agent based on a metal-organic coordination polymer as a drug-loading framework for effective combination therapy. Acta Biomater. 2019; 94:435-446. DOI: 10.1016/j.actbio.2019.06.014. View

Ngiow S, Von Scheidt B, Akiba H, Yagita H, Teng M, Smyth M . Anti-TIM3 antibody promotes T cell IFN-γ-mediated antitumor immunity and suppresses established tumors. Cancer Res. 2011; 71(10):3540-51. DOI: 10.1158/0008-5472.CAN-11-0096. View

10.

Luo L, Yang J, Zhu C, Jiang M, Guo X, Li W . Sustained release of anti-PD-1 peptide for perdurable immunotherapy together with photothermal ablation against primary and distant tumors. J Control Release. 2018; 278:87-99. DOI: 10.1016/j.jconrel.2018.04.002. View

11.

Topfer K, Kempe S, Muller N, Schmitz M, Bachmann M, Cartellieri M . Tumor evasion from T cell surveillance. J Biomed Biotechnol. 2011; 2011:918471. PMC: 3228689. DOI: 10.1155/2011/918471. View

12.

Ariyan C, Brady M, Siegelbaum R, Hu J, Bello D, Rand J . Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade. Cancer Immunol Res. 2018; 6(2):189-200. PMC: 6857638. DOI: 10.1158/2326-6066.CIR-17-0356. View

13.

Sweeney E, Cano-Mejia J, Fernandes R . Photothermal Therapy Generates a Thermal Window of Immunogenic Cell Death in Neuroblastoma. Small. 2018; 14(20):e1800678. DOI: 10.1002/smll.201800678. View

14.

Meng F, Wang J, Ping Q, Yeo Y . Camouflaging Nanoparticles for Ratiometric Delivery of Therapeutic Combinations. Nano Lett. 2019; 19(3):1479-1487. PMC: 6417971. DOI: 10.1021/acs.nanolett.8b04017. View

15.

Huang T, Huang G, Zhang C, Zhuang B, Liu B, Su L . Supramolecular Photothermal Nanomedicine Mediated Distant Tumor Inhibition via PD-1 and TIM-3 Blockage. Front Chem. 2020; 8:1. PMC: 7034522. DOI: 10.3389/fchem.2020.00001. View

16.

Hanagata N . Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system. Int J Nanomedicine. 2012; 7:2181-95. PMC: 3356174. DOI: 10.2147/IJN.S30197. View

17.

Gong P, Guo L, Pang M, Wang D, Sun L, Tian Z . Nano-sized paramagnetic and fluorescent fluorinated carbon fiber with high NIR absorbance for cancer chemo-photothermal therapy. J Mater Chem B. 2020; 6(19):3068-3077. DOI: 10.1039/c7tb03320f. View

18.

Chen W, Qin M, Chen X, Wang Q, Zhang Z, Sun X . Combining photothermal therapy and immunotherapy against melanoma by polydopamine-coated AlO nanoparticles. Theranostics. 2018; 8(8):2229-2241. PMC: 5928883. DOI: 10.7150/thno.24073. View

19.

Garg A, Dudek-Peric A, Romano E, Agostinis P . Immunogenic cell death. Int J Dev Biol. 2015; 59(1-3):131-40. DOI: 10.1387/ijdb.150061pa. View

20.

Qian M, Chen L, Du Y, Jiang H, Huo T, Yang Y . Biodegradable Mesoporous Silica Achieved via Carbon Nanodots-Incorporated Framework Swelling for Debris-Mediated Photothermal Synergistic Immunotherapy. Nano Lett. 2019; 19(12):8409-8417. DOI: 10.1021/acs.nanolett.9b02448. View